Paul Tudor Jones II's position in 10x Genomics is currently worth $1.75 Million. That's 0.02% of their equity portfolio (735th largest holding). The first 10x Genomics trade was made in Q3 2019. Since then Paul Tudor Jones II bought shares ten more times and sold shares on six occasions. The investor's estimated purchase price is $7.27 Million, resulting in a loss of 76%.